COPD is the third leading cause worldwide of death. It affects one in every four people and one in every six women over 95.
COPD is a term that refers to a variety of conditions that restrict airflow to the lungs. Studies show that COPD patients are more likely to develop diabetes, cardiovascular disease and hypertension. The European Respiratory Journal October 2008 issue reported that more than half of patients with COPD will eventually develop diabetes or cardiovascular disease.
More than 32 million COPD patients have been diagnosed in the United States. The majority of patients who have COPD require oxygen therapy. Patients can find oxygen therapy machines difficult to use. Many companies are working on devices to make oxygen therapy more convenient and effective. Ingen Medical Devices has developed the Oxyview. This gauge tells patients when their equipment is malfunctioning.
Dr. Rozenbaum is a prominent scientist who serves as a Board Member for several national COPD organizations. He also founded COPD Alert. “great idea.” “This very small and simple-to-operate, yet very accurate gauging device provides a high measure of security to patients, who can quickly be alerted to malfunctioning equipment and take the necessary steps to correct the situation or immediately contact their oxygen provider.”Oxyview comes with a lifetime warranty and is the only product of its type in the current respiratory market.
Adds Dr. Rozenbaum, “I know of many patients who consider Oxyview a very important part of their oxygen therapy.”
Patients with COPD will increase as medical technology improves and the average lifespan is extended. An analysis by the National Center for Health Statistics, Centers for Disease Control and Prevention shows that Americans born in 2004 will live an average of 77.9, with women living longer than the men. COPD is currently the fifth leading cause for death in the United States.
Visit www.amazon.com for more information www.ingen-tech.com.
